trastuzumab deruxtecan,fruquintinib
daiichi sankyo,hutchmed,astrazeneca
['lba25', 'colorectal', 'crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)', 'fresco-2', 'rectal', 'crcsm']
#esmo22 today 11am:lba25 phase 3 fresco-2 will be presented in previously treated metastatic #colorectal #cancer. #clinical trials #cancerresearch discussant: #crcsm #academictwitter 
Co-Director/Co-Leader GI Oncology Research; Director, Young Adult Cancers Program; Co-Chair, NCI GI Steering Committee; and Director for Strategic Relations